MIF and neoplasm: When treated with recombinant MIF (rMIF) at doses in the range of 0–150 ng/ml, MCF-12A and both tumor cell lines demonstrated increased proliferation, with the strongest effect observed in cells with the highest CD74 expression which are MDA-MB-231.